Crocin

PreclinicalSmall molecule

MMashhad University of Medical Sciences

Crocin is one of 29 small molecule programs targeting Breast Cancer. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Breast CancerActive, not recruiting

Breast CancerPreclinical

Active, not recruiting

Competition

Competitive Landscape

702 competitors in Breast Cancer

#DrugCompanyPhaseTrials

Adenocard

Astellas

Preclinical

2 2

Recombinant Human Endostatin

PPeking University Third Hospital

Preclinical

1 3

Tianeptine

Pfizer

Preclinical

1 4

Ablavar

LLantheus Medical Imaging

Preclinical

2 5

Diuretic

RReprieve Cardiovascular, Inc

Preclinical

1 6

Tc99m Sestamibi

MM.D. Anderson Cancer Center

Preclinical

2 7

Naltrexone/bupropion

Novo Nordisk

Preclinical

1 8

Motexafin Gadolinium

PPharmacyclics LLC.

Preclinical

1 9

Perflutren Lipid Microsphere

IImaRx Therapeutics

Preclinical

1 10

Sertraline ODT

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Breast Cancer2 trials

Follow up Study of Crocin on Cardiac Function Protection in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy Based on Color Doppler Ultrasound Combined With Myocardial Zymogram

Active, not recruiting·MMei Zhang··NCT06187818·120 enrolled

Protection of Cardiovascular Function With Crocin in BrEast Cancer Patients Undergoing Radiotherapy and Chemotherapy

Unknown status·QQilu Hospital of Shandong University·N/A·NCT05504148·120 enrolled

Osteoarthritis1 trial

Evaluation Effect of Crocina on The Cellular Immune Responses in Osteoarthritis Patients

Unknown status·MMashhad University of Medical Sciences·Phase 3·NCT03375814·40 enrolled

Unspecified1 trial

Crocin Supplementation in CSCR

Unknown status·SShiraz University of Medical Sciences·Phase 1·NCT04936490·40 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Crocin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Crocin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Crocin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Mashhad University of Medical Sciences company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: MMashhad University of Medical Sciences

Crocin

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Breast Cancer2 trials

Osteoarthritis1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News